Feasibility of simultaneous dual-isotope myocardial perfusion acquisition using a lower dose of sestamibi

The feasibility of simultaneous dual-isotope myocardial perfusion imaging was assessed using a ca. 12 mCi dose of technetium-99m sestamibi (MIBI) and ca. 3 mCi thallium-201. Planar and single-photon emission tomographic (SPET) data from 40 patients (41 studies) imaged with both a single- and a dual-isotope protocol were analyzed. Rest injected 201Tl (pure-Tl) images were acquired using 20% windows at 70 and 166 keV about 15 min after the 201Tl injection. Patients were then stressed, and at peak stress 99mTc-sestamibi was injected. About 30 min later 99mTc data were recorded with a 20% window center at 140 keV, and simultaneous 201Tl (dual-Tl) data were recorded with a single 20% window centered at 80 keV. Total myocardial counts based on SPET data in the dual-T1 images were increased by 18.61%±2.91% (SEM) (range: -12.8% to 84.1%) compared to pure-Tl images. Region of interest analysis revealed the greater increase in counts in the apical region and the least in the lateral wall. Pure Tl and dual-Tl images were visually evaluated for image quality (IQ) on a five-point scale (0=uncacceptable to 4=excellent). Dual-Tl IQ was lower than that of pure-Tl in 61% of cases, and similar in 37% (12% of the pure-Tl and 41% of the dual-Tl images fell into the 0 and 1 categories). Thallium perfusion abnormalities were of similar extent in 70% of segments, less severe in 18%, and more severe in 12%. There was an inverse correlation with patient weight, such that patients weighing more than 180 lbs had substantially worse images than those below this cutoff value. While dual-tracer images are of lower quality, they are interpretable if the patient is not severely overweight. (orig.)